Cannabis use, risk behaviours and harms in Brazil: A comprehensive review of available data indicators.

Dimitri Daldegan-Bueno Sheila Rubia Lindner Douglas Francisco Kovaleski Benedikt Fischer

Published in: Drug and alcohol review (2022)

The prevalence of cannabis use in Brazil is comparably low (e.g., relative to elsewhere in the Americas). Data on numerous key cannabis-related indicators is absent, or limited in scope for Brazil. Considering ongoing evolutions in cannabis control and its status as the most common illicit drug, more comprehensive surveillance of cannabis use and related outcomes is advised.

Keyphrases

electronic health record
public health
big data
emergency department
type diabetes
data analysis
adverse drug
deep learning
insulin resistance
glycemic control